Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing novel therapeutic concepts/targets related to neurodegenerative disorders or genetic neurological diseases. One‑year projects will be funded up to JPY 10,000,000 or equivalent amount, including indirect costs.
Diseases of particular interest: amyotrophic lateral sclerosis, frontotemporal lobar degeneration, Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, Down’s syndrome with Alzheimer’s disease, cerebral amyloid angiopathy...
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.